Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

2.

Whole-Genome Sequences of Staphylococcus aureus Isolates from Cystic Fibrosis Lung Infections.

Bernardy EE, Petit RA 3rd, Moller AG, Blumenthal JA, McAdam AJ, Priebe GP, Chande AT, Rishishwar L, Jordan IK, Read TD, Goldberg JB.

Microbiol Resour Announc. 2019 Jan 17;8(3). pii: e01564-18. doi: 10.1128/MRA.01564-18. eCollection 2019 Jan.

3.

Variability in antimicrobial use in pediatric ventilator-associated events.

Karandikar MV, Coffin SE, Priebe GP, Sandora TJ, Logan LK, Larsen GY, Toltzis P, Gray JE, Klompas M, Sammons JS, Harper MB, Horan K, Lakoma M, Cocoros NM, Lee GM.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):32-39. doi: 10.1017/ice.2018.264. Epub 2018 Nov 9.

PMID:
30409233
4.

Progress Toward the Elusive Pseudomonas aeruginosa Vaccine.

Merakou C, Schaefers MM, Priebe GP.

Surg Infect (Larchmt). 2018 Nov/Dec;19(8):757-768. doi: 10.1089/sur.2018.233. Epub 2018 Nov 15. Review.

PMID:
30388058
5.

PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.

Schaefers MM, Duan B, Mizrahi B, Lu R, Reznor G, Kohane DS, Priebe GP.

Vaccine. 2018 Nov 12;36(46):6926-6932. doi: 10.1016/j.vaccine.2018.10.010. Epub 2018 Oct 9.

PMID:
30314911
6.

Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis.

Barsky EE, Pereira LM, Sullivan KJ, Wong A, McAdam AJ, Sawicki GS, Priebe GP, Goobie SM.

J Cyst Fibros. 2018 May;17(3):e25-e31. doi: 10.1016/j.jcf.2017.10.010. Epub 2017 Nov 2.

PMID:
29103924
7.

Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.

Barsky EE, Williams KA, Priebe GP, Sawicki GS.

Pediatr Pulmonol. 2017 Oct;52(10):1276-1282. doi: 10.1002/ppul.23781. Epub 2017 Aug 16.

PMID:
28815999
8.

Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Roux D, Weatherholt M, Clark B, Gadjeva M, Renaud D, Scott D, Skurnik D, Priebe GP, Pier G, Gerard C, Yoder-Himes DR.

Infect Immun. 2017 May 23;85(6). pii: e00765-16. doi: 10.1128/IAI.00765-16. Print 2017 Jun.

9.

Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung.

Chung H, Lieberman TD, Vargas SO, Flett KB, McAdam AJ, Priebe GP, Kishony R.

Nat Commun. 2017 Jan 19;8:14078. doi: 10.1038/ncomms14078.

10.

An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity.

Schaefers MM, Liao TL, Boisvert NM, Roux D, Yoder-Himes D, Priebe GP.

PLoS Pathog. 2017 Jan 3;13(1):e1006116. doi: 10.1371/journal.ppat.1006116. eCollection 2017 Jan.

11.

From the Cover: Prolonged Exposure to Volatile Anesthetic Isoflurane Worsens the Outcome of Polymicrobial Abdominal Sepsis.

Koutsogiannaki S, Schaefers MM, Okuno T, Ohba M, Yokomizo T, Priebe GP, DiNardo JA, Sulpicio SG, Yuki K.

Toxicol Sci. 2017 Apr 1;156(2):402-411. doi: 10.1093/toxsci/kfw261.

12.

Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens.

Zhao G, Zaidi TS, Bozkurt-Guzel C, Zaidi TH, Lederer JA, Priebe GP, Pier GB.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6797-6804. doi: 10.1167/iovs.16-20358.

13.

A Pediatric Approach to Ventilator-Associated Events Surveillance.

Cocoros NM, Priebe GP, Logan LK, Coffin S, Larsen G, Toltzis P, Sandora TJ, Harper M, Sammons JS, Gray JE, Goldmann D, Horan K, Burton M, Checchia PA, Lakoma M, Sims S, Klompas M, Lee GM.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):327-333. doi: 10.1017/ice.2016.277. Epub 2016 Dec 5.

PMID:
27917737
14.

Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia.

Albert BD, Zurakowski D, Bechard LJ, Priebe GP, Duggan CP, Heyland DK, Mehta NM.

Pediatr Crit Care Med. 2016 Oct;17(10):924-929.

15.

Ventilator-Associated Events in Neonates and Children--A New Paradigm.

Cocoros NM, Kleinman K, Priebe GP, Gray JE, Logan LK, Larsen G, Sammons J, Toltzis P, Miroshnik I, Horan K, Burton M, Sims S, Harper M, Coffin S, Sandora TJ, Hocevar SN, Checchia PA, Klompas M, Lee GM; Pediatric Ventilator-Associated Conditions Study Team.

Crit Care Med. 2016 Jan;44(1):14-22. doi: 10.1097/CCM.0000000000001372.

PMID:
26524075
16.

Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia.

Gauguet S, D'Ortona S, Ahnger-Pier K, Duan B, Surana NK, Lu R, Cywes-Bentley C, Gadjeva M, Shan Q, Priebe GP, Pier GB.

Infect Immun. 2015 Oct;83(10):4003-14. doi: 10.1128/IAI.00037-15. Epub 2015 Jul 27.

17.

Impact of Mandatory Public Reporting of Central Line-Associated Bloodstream Infections on Blood Culture and Antibiotic Utilization in Pediatric and Neonatal Intensive Care Units.

Flett KB, Ozonoff A, Graham DA, Sandora TJ, Priebe GP.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):878-85. doi: 10.1017/ice.2015.100. Epub 2015 Apr 27.

PMID:
25913602
18.

Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.

Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, Magill SS, Maragakis LL, Priebe GP, Speck K, Yokoe DS, Berenholtz SM.

Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S133-54. No abstract available.

PMID:
25376073
19.

Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.

Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, Magill SS, Maragakis LL, Priebe GP, Speck K, Yokoe DS, Berenholtz SM; Society for Healthcare Epidemiology of America (SHEA).

Infect Control Hosp Epidemiol. 2014 Aug;35(8):915-36. doi: 10.1086/677144. No abstract available.

PMID:
25026607
20.

Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.

Zaidi T, Zaidi T, Cywes-Bentley C, Lu R, Priebe GP, Pier GB.

Infect Immun. 2014 Aug;82(8):3483-91. doi: 10.1128/IAI.01951-14. Epub 2014 Jun 9.

21.

Vaccines for Pseudomonas aeruginosa: a long and winding road.

Priebe GP, Goldberg JB.

Expert Rev Vaccines. 2014 Apr;13(4):507-19. doi: 10.1586/14760584.2014.890053. Epub 2014 Feb 27. Review.

22.

Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures.

Lieberman TD, Flett KB, Yelin I, Martin TR, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2014 Jan;46(1):82-7. doi: 10.1038/ng.2848. Epub 2013 Dec 8.

23.

Trehalose biosynthesis promotes Pseudomonas aeruginosa pathogenicity in plants.

Djonović S, Urbach JM, Drenkard E, Bush J, Feinbaum R, Ausubel JL, Traficante D, Risech M, Kocks C, Fischbach MA, Priebe GP, Ausubel FM.

PLoS Pathog. 2013 Mar;9(3):e1003217. doi: 10.1371/journal.ppat.1003217. Epub 2013 Mar 7.

24.

Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity.

Hong H, Morrow DF, Sandora TJ, Priebe GP.

Am J Infect Control. 2013 Aug;41(8):e77-9. doi: 10.1016/j.ajic.2012.10.018. Epub 2013 Feb 7.

PMID:
23394859
25.

Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.

Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP.

J Infect Dis. 2013 Jan 1;207(1):39-49. doi: 10.1093/infdis/jis657. Epub 2012 Oct 24.

26.

Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.

Tamang DL, Pirzai W, Priebe GP, Traficante DC, Pier GB, Falck JR, Morisseau C, Hammock BD, McCormick BA, Gronert K, Hurley BP.

J Immunol. 2012 Nov 15;189(10):4960-9. doi: 10.4049/jimmunol.1201922. Epub 2012 Oct 8.

27.

Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology.

Zaidi TS, Zaidi T, Pier GB, Priebe GP.

Infect Immun. 2012 Oct;80(10):3706-12. doi: 10.1128/IAI.00249-12. Epub 2012 Jul 16.

28.

Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.

Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP.

Am J Respir Crit Care Med. 2012 Sep 1;186(5):420-7. doi: 10.1164/rccm.201202-0182OC. Epub 2012 Jun 21.

29.

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Skurnik D, Davis MR Jr, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP.

J Infect Dis. 2012 Jun;205(11):1709-18. doi: 10.1093/infdis/jis254. Epub 2012 Mar 23.

30.

Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.

Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, Davis MR Jr, Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2011 Nov 13;43(12):1275-80. doi: 10.1038/ng.997.

31.

Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.

Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB.

Infect Immun. 2011 Mar;79(3):1289-99. doi: 10.1128/IAI.01139-10. Epub 2010 Dec 13.

32.

Caveolin-1 modifies the immunity to Pseudomonas aeruginosa.

Gadjeva M, Paradis-Bleau C, Priebe GP, Fichorova R, Pier GB.

J Immunol. 2010 Jan 1;184(1):296-302. doi: 10.4049/jimmunol.0900604. Epub 2009 Nov 30.

33.

Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model.

Kamei A, Koh AY, Gadjeva M, Priebe GP, Lory S, Pier GB.

J Infect Dis. 2010 Jan 1;201(1):71-80. doi: 10.1086/648616.

34.

Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.

Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB.

Infect Immun. 2009 Dec;77(12):5300-10. doi: 10.1128/IAI.00501-09. Epub 2009 Oct 5.

35.

IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB.

J Immunol. 2008 Oct 1;181(7):4965-75.

36.

The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection.

Benarafa C, Priebe GP, Remold-O'Donnell E.

J Exp Med. 2007 Aug 6;204(8):1901-9. Epub 2007 Jul 30.

38.

Sepsis in the immunocompromised child: the least studied with the most to gain.

Priebe GP.

Pediatr Crit Care Med. 2005 May;6(3 Suppl):S78-9. No abstract available.

PMID:
15864109
39.
40.

Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.

Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L.

J Immunol. 2004 Nov 1;173(9):5671-8. Erratum in: J Immunol. 2007 Jun 1;178(11):7485.

41.

The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.

Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, Coutinho YS, Noto MJ, Urban TA, Pier GB, Goldberg JB.

Infect Immun. 2004 Jul;72(7):4224-32.

42.
43.

High-frequency oscillatory ventilation in pediatric patients.

Priebe GP, Arnold JH.

Respir Care Clin N Am. 2001 Dec;7(4):633-45. Review.

PMID:
11926760
44.

Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.

Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB.

Infect Immun. 2002 Mar;70(3):1507-17.

45.

Bacterial subretinal abscess: a case report and review of the literature.

Harris EW, D'Amico DJ, Bhisitkul R, Priebe GP, Petersen R.

Am J Ophthalmol. 2000 Jun;129(6):778-85. Review.

PMID:
10926988
47.

Continuous improvement learning for residents.

Headrick LA, Richardson A, Priebe GP.

Pediatrics. 1998 Apr;101(4 Pt 2):768-73; discussion 773-4.

PMID:
9544181

Supplemental Content

Loading ...
Support Center